Biotech

All Articles

Acepodia, Pfizer click on together for chemistry-based cell therapy

.Phone it a scenario of really good chemical make up: Acepodia, a biotech based on Nobel Champion sc...

Praxis epilepsy drug lessens seizures in phase 2 trial

.Praxis Accuracy Medicines has actually racked up an additional midphase win in epilepsy this year, ...

Three execs surrender as Dyne messages blended records for DMD candidate

.After getting away from a medical hold many years back, Dyne Rehab has exposed new period 1/2 recor...

Arrowhead fires off stage 3 information in uncommon metabolic ailment before market clash with Ionis

.Arrowhead Pharmaceuticals has presented its own hand in front of a possible face-off along with Ion...

Pfizer, Valneva show lyme ailment go successful for 2nd enhancer

.Pfizer and also Valneva may have about pair of even more years to wait just before they make the in...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Let's dive into a conversation along with Ayla Ellison, Strong Biotech Managing Editor as well as M...

New data show how Bayer's asundexian failed to stop strokes

.Bayer suspended the phase 3 test for its own aspect XIa inhibitor asundexian behind time in 2013 af...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, managers ...

Galapagos' stock up as fund presents intent to shape its own development

.Galapagos is coming under added tension coming from entrepreneurs. Having created a 9.9% concern in...

Cell- focused Sana scoops initial CSO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings a...